Goldman Sachs makes substantial downward adjustment to Pacific Biosciences stock

Retrieved on: 2024-04-18 20:12:18

Tags for this article:

Click the tags to see associated articles and topics

Goldman Sachs makes substantial downward adjustment to Pacific Biosciences stock. View article details on hiswai:

Excerpt

On Thursday, Goldman Sachs adjusted its stance on Pacific Biosciences (NASDAQ:PACB) of California (NASDAQ:PACB), shifting the rating from Buy to ...

Article found on: www.investing.com